Results 91 to 100 of about 354 (138)

Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial. [PDF]

Nat Commun
Mooradian MJ, Fintelmann FJ, LaSalle TJ, Simon J, Graur A, Muzikansky A, Mino-Kenudson M, Shalhout S, Kaufman HL, Jenkins RW, Lawrence D, Lawless A, Sharova T, Uppot RN, Fang J, Blaum EM, Gonye ALK, Gushterova I, Boland GM, Azzoli C, Hacohen N, Sade-Feldman M, Sullivan RJ.   +22 more
europepmc   +1 more source

Synergistic Regulation of Plankton Communities by Polyculture of Grass Carp and Crucian Carp: Seasonal Dynamics and Interaction Networks Based on eDNA. [PDF]

Biology (Basel)
Shao L, Guo H, Zhou Y, Li H, Li W, Wang C, Guo L, Luo K, Shen Z.   +8 more
europepmc   +1 more source

SEG 62-1092. Ankyra. Corpus.

core   +1 more source

Overcoming impaired antigen presentation in tumor-draining lymph nodes facilitates immunotherapy. [PDF]

J Immunother Cancer
O'Melia MJ, Menzel L, Lei PJ, Zhou H, Zhang X, Contreras-Alvarado N, Rajotte JJ, Liu L, Nikmaneshi MR, Baish JW, Ubellacker JM, Boland GM, Cohen S, Padera TP, Munn LL.   +14 more
europepmc   +1 more source

Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling. [PDF]

Nat Methods
Cheng AP, Widman AJ, Arora A, Rusinek I, Sossin A, Rajagopalan S, Midler N, Hooper WF, Murray RM, Halmos D, Langanay T, Chu H, Inghirami G, Potenski C, Germer S, Marton M, Manaa D, Helland A, Furatero R, McClintock J, Winterkorn L, Steinsnyder Z, Wang Y, Alimohamed AI, Malbari MS, Saxena A, Callahan MK, Frederick DT, Spain L, Sigouros M, Manohar J, King A, Wilkes D, Otilano J, Elemento O, Mosquera JM, Jaimovich A, Lipson D, Turajlic S, Zody MC, Altorki NK, Wolchok JD, Postow MA, Robine N, Faltas BM, Boland G, Landau DA.   +46 more
europepmc   +1 more source

YENİ ARKEOLOJİK ARAŞTIRMALAR IŞIĞINDA MHTPOΠΟΛΙΣ THΣ ΓΑΛΑΤΙΑΣ: ANKYRA

, 2019
KADIOĞLU, Musa;GÖRKAY, Kutalmış
core   +1 more source

Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. [PDF]

J Clin Oncol
Luke JJ, Ascierto PA, Khattak MA, de la Cruz Merino L, Del Vecchio M, Rutkowski P, Spagnolo F, Mackiewicz J, Chiarion-Sileni V, Kirkwood JM, Robert C, Grob JJ, de Galitiis F, Schadendorf D, Carlino MS, Wu XL, Fukunaga-Kalabis M, Krepler C, Eggermont AMM, Long GV.   +19 more
europepmc   +1 more source

Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator. [PDF]

J Clin Oncol
Varey AHR, Li I, El Sharouni MA, Simon J, Dedeilia A, Ch'ng S, Saw RPM, Spillane AJ, Shannon KF, Pennington TE, Rtshiladze M, Stretch JR, Nieweg OE, van Akkooi A, Sullivan RJ, Boland GM, Gershenwald JE, van Diest PJ, Scolyer RA, Long GV, Thompson JF, Lo SN.   +21 more
europepmc   +1 more source

Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting. [PDF]

Clin Cancer Res
Ventin M, Cattaneo G, Arya S, Jia J, Gelmi MC, Sun Y, Maggs L, Ksander BR, Verdijk RM, Boland GM, Jenkins RW, Haq R, Jager MJ, Wang X, Ryeom S, Ferrone CR.   +15 more
europepmc   +1 more source

Mechanisms, Microenvironments, and Models: Understanding Therapeutic Resistance in Glioblastoma. [PDF]

Int J Radiat Oncol Biol Phys
Wisdom AJ, Temple H, Cui Y, Del Vecchio CT, Kim T, White FM, Floyd SR, Spranger S.   +7 more
europepmc   +1 more source